Results 171 to 180 of about 11,700 (225)

Latanoprost uptake and release from commercial contact lenses

, 2019
Ryan Horne, Joseph Rich, Matthew W. Bradley, William G. Pitt   +3 more
openalex   +2 more sources

Preservative-Free Gel-Formulated Glaucoma Therapies: Learning from the Past, Looking to the Future. [PDF]

Adv Ther
Konstas AG, Holló G, Boboridis KG.
europepmc   +1 more source

Impact of Antiglaucoma Drug Number and Class on Corneal Epithelial Thickness Measured by OCT. [PDF]

Pharmaceuticals (Basel)
Miklaszewski P, Gadamer AM, Janiszewska-Bil D, Lyssek-Boroń A, Dobrowolski D, Wylęgała E, Grabarek BO, Koss MJ, Krysik K.   +8 more
europepmc   +1 more source

Comparison of latanoprost, brimonidine tartrate, and bimatoprost plus timolol maleate in fixed combinations

, 2013
Güliz Fatma Yavaş, Tuncay Küsbeci, Onur Polat, Mahmut Karadaş, Sıtkı Samet Ermiş, Ümit Ubeyt İnan   +5 more
openalex   +2 more sources

A phase III study comparing preservative-free latanoprost eye drop emulsion with preserved latanoprost in open-angle glaucoma or ocular hypertension. [PDF]

Eye (Lond)
Baudouin C, Stalmans I, Bourne R, Larrosa JM, Schmickler S, Seleznev A, Oddone F, Phase III study group.   +7 more
europepmc   +1 more source

Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma. [PDF]

Drug Deliv
Ana González-Cela-Casamayor M, Rodrigo MJ, Brugnera M, Munuera I, Martínez-Rincón T, Prats-Lluís C, Villacampa P, García-Feijoo J, Pablo LE, Bravo-Osuna I, Garcia-Martin E, Herrero-Vanrell R.   +11 more
europepmc   +1 more source

Real-world impact of latanoprostene bunod ophthalmic solution 0.024% in glaucoma therapy: a narrative review. [PDF]

Front Ophthalmol (Lausanne)
Stamer WD, Chiu T, Lu DW, Wang TH, Rojanapongpun P, Ruangvaravate N, Jo YH, Moster MR, Fingeret M, Cothran NL, Steen J, Gaddie IB, Uçakhan-Gündüz Ö, Shamseldin Shalaby W, Hutnik CML.   +14 more
europepmc   +1 more source

The Effect of Ocular Hypotensive Medications on Posterior Segment Blood Flow in Healthy Subjects: A Prospective, Randomized, and Interventional Study. [PDF]

J Curr Ophthalmol
Shokouhi Rad S, Ghannad M, Shoeibi N, Bakhtiari E, Heidarzadeh HR.   +4 more
europepmc   +1 more source

Development of a conjunctival contact-type drug delivery device for latanoprost using hyaluronic acid. [PDF]

Drug Deliv
Lee S, Jung MY, Park CY.
europepmc   +1 more source

Comparative Efficacy and Safety of Netarsudil-Containing Interventions for Intraocular Pressure Control: A Systematic Review and Network Meta-Analysis. [PDF]

Cureus
Awan B, Elsaigh M, Tariq A, Badee M.
europepmc   +1 more source